| Dr Rachelle Elizabeth Mccabe, DNP, ARNP, FNP-C | |
|
1111 Duff Ave Ste 2607, Ames, IA 50010-5745 | |
| (515) 327-2000 | |
| (515) 327-2019 |
| Full Name | Dr Rachelle Elizabeth Mccabe |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 1111 Duff Ave Ste 2607, Ames, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255958005 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | A159466 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Belmond Community Hospital | 1052201852 | 66 |
News Archive
Researchers are one step closer to providing a new therapy for colon cancer, after findings revealed that a small molecule focal adhesion kinase (FAK) inhibitor known as Y15 effectively blocked cell viability, promoted detachment and apoptosis, and decreased tumor growth in mice. These findings were presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held Oct. 27-30, 2010.
New research published in the journal Nature Chemical Biology shows that a group of scientists, led by faculty at the University of Notre Dame, has made concrete progress toward the development of the first-ever inhibitory therapeutic for Type I hypersensitive allergic reactions.
UCSF scientists have discovered that a tiny filament extending from cells, until recently regarded as a remnant of evolution, may play a role in the most common malignant brain tumor in children.
An active ingredient in eye drops that were being developed for the treatment of a form of eye disease has shown promise for treating an aggressive form of blood cancer. Scientists at the Wellcome Sanger Institute, University of Cambridge, University of Nottingham and their collaborators have found that this compound, which targets an essential cancer gene, could kill leukemia cells without harming non-leukemic blood cells.
Google researchers along with those from its health technology subsidary Verily Life Sciences, have created a new way with which a person's heart attack risk may be predicted.
› Verified 9 days ago
| Entity Name | Iowa Specialty Hospital- Clarion |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396760153 PECOS PAC ID: 3375451347 Enrollment ID: O20031120000622 |
News Archive
Researchers are one step closer to providing a new therapy for colon cancer, after findings revealed that a small molecule focal adhesion kinase (FAK) inhibitor known as Y15 effectively blocked cell viability, promoted detachment and apoptosis, and decreased tumor growth in mice. These findings were presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held Oct. 27-30, 2010.
New research published in the journal Nature Chemical Biology shows that a group of scientists, led by faculty at the University of Notre Dame, has made concrete progress toward the development of the first-ever inhibitory therapeutic for Type I hypersensitive allergic reactions.
UCSF scientists have discovered that a tiny filament extending from cells, until recently regarded as a remnant of evolution, may play a role in the most common malignant brain tumor in children.
An active ingredient in eye drops that were being developed for the treatment of a form of eye disease has shown promise for treating an aggressive form of blood cancer. Scientists at the Wellcome Sanger Institute, University of Cambridge, University of Nottingham and their collaborators have found that this compound, which targets an essential cancer gene, could kill leukemia cells without harming non-leukemic blood cells.
Google researchers along with those from its health technology subsidary Verily Life Sciences, have created a new way with which a person's heart attack risk may be predicted.
› Verified 9 days ago
| Entity Name | Belmond Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821122623 PECOS PAC ID: 1052201852 Enrollment ID: O20040316001360 |
News Archive
Researchers are one step closer to providing a new therapy for colon cancer, after findings revealed that a small molecule focal adhesion kinase (FAK) inhibitor known as Y15 effectively blocked cell viability, promoted detachment and apoptosis, and decreased tumor growth in mice. These findings were presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held Oct. 27-30, 2010.
New research published in the journal Nature Chemical Biology shows that a group of scientists, led by faculty at the University of Notre Dame, has made concrete progress toward the development of the first-ever inhibitory therapeutic for Type I hypersensitive allergic reactions.
UCSF scientists have discovered that a tiny filament extending from cells, until recently regarded as a remnant of evolution, may play a role in the most common malignant brain tumor in children.
An active ingredient in eye drops that were being developed for the treatment of a form of eye disease has shown promise for treating an aggressive form of blood cancer. Scientists at the Wellcome Sanger Institute, University of Cambridge, University of Nottingham and their collaborators have found that this compound, which targets an essential cancer gene, could kill leukemia cells without harming non-leukemic blood cells.
Google researchers along with those from its health technology subsidary Verily Life Sciences, have created a new way with which a person's heart attack risk may be predicted.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rachelle Elizabeth Mccabe, DNP, ARNP, FNP-C 1278 Edgebrook Dr, Story City, IA 50248-9533 Ph: (515) 460-4051 | Dr Rachelle Elizabeth Mccabe, DNP, ARNP, FNP-C 1111 Duff Ave Ste 2607, Ames, IA 50010-5745 Ph: (515) 327-2000 |
News Archive
Researchers are one step closer to providing a new therapy for colon cancer, after findings revealed that a small molecule focal adhesion kinase (FAK) inhibitor known as Y15 effectively blocked cell viability, promoted detachment and apoptosis, and decreased tumor growth in mice. These findings were presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held Oct. 27-30, 2010.
New research published in the journal Nature Chemical Biology shows that a group of scientists, led by faculty at the University of Notre Dame, has made concrete progress toward the development of the first-ever inhibitory therapeutic for Type I hypersensitive allergic reactions.
UCSF scientists have discovered that a tiny filament extending from cells, until recently regarded as a remnant of evolution, may play a role in the most common malignant brain tumor in children.
An active ingredient in eye drops that were being developed for the treatment of a form of eye disease has shown promise for treating an aggressive form of blood cancer. Scientists at the Wellcome Sanger Institute, University of Cambridge, University of Nottingham and their collaborators have found that this compound, which targets an essential cancer gene, could kill leukemia cells without harming non-leukemic blood cells.
Google researchers along with those from its health technology subsidary Verily Life Sciences, have created a new way with which a person's heart attack risk may be predicted.
› Verified 9 days ago
Carl Markley, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 420 Kellogg Ave, Ames, IA 50010 Phone: 515-233-3141 | |
Emily Black, ARNP PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 600 5th St, Ames, IA 50010 Phone: 515-233-1122 | |
Alyson Vosberg, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3815 Stange Rd, Ames, IA 50010 Phone: 515-956-4050 | |
Mary Ramen, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Isu Thomas B. Thielen Student Health Center, Union & Sheldon, Ames, IA 50011 Phone: 515-294-5801 Fax: 515-294-7180 | |
Lindsay Eileen Hannapel, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2530 Chamberlain St, Ames, IA 50014 Phone: 877-849-0763 | |
Marie Burrows, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Iowa State University, 2260 Thielen Student Health Center, Ames, IA 50011 Phone: 515-294-7265 Fax: 515-294-5457 | |
Jennifer K Britten, A.R.N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1816 Philadelphia St, Ames, IA 50010 Phone: 515-232-2500 Fax: 515-663-4131 |